
Aesthetic Treatment
Dermal Filler
Two filler categories. One clinical decision — made for your anatomy, not by default.
Dermal fillers are not interchangeable. The choice between a hyaluronic acid filler like Restylane and a calcium-based product like Radiesse is a clinical decision — one that depends on the area being treated, the depth of correction needed, the longevity expected, and the tissue environment. At Veritas Backstage, that choice is made in that context, not by habit or convenience.
Hyaluronic acid fillers (Restylane) are the most versatile category. HA is a substance naturally produced by the body. The filler is a gel that temporarily restores volume in a targeted area and is fully reversible with hyaluronidase if needed. Restylane products come in a range of formulations suited to specific depths and areas: finer gels for delicate tissue like the tear trough, denser products for structural work in the cheeks, chin, and jawline.
Radiesse is a calcium hydroxyapatite filler — a thicker, more robust product suited to deeper structural work. Unlike HA fillers, it is not reversible, but it offers a longer duration and also stimulates the body’s own collagen production over time. This mild biostimulatory effect makes it well-suited to areas requiring significant structural support: the cheeks, chin, jawline, and hands.
The product recommendation is made during consultation. There is no single correct filler — there is the correct filler for this patient, in this area, at this stage of aging.
THE EXPERIENCE
Filler appointments begin with a brief assessment and treatment plan review. For established patients, this is a confirmation of the plan. For new patients, it includes a full facial analysis and a discussion of which products and techniques are most appropriate for the anatomy and goals being addressed.
Treatment time varies by area and the complexity of the plan. Most single-area appointments are complete in 30 to 45 minutes; multi-area or liquid facelift protocols may take up to 90 minutes. A topical numbing cream or dental block is applied before treatment begins. Filler is delivered through a very fine needle or, for larger areas, a blunt cannula — which reduces bruising and allows for more even, controlled placement.
Swelling is expected for 24 to 72 hours and is more pronounced in certain areas — particularly the lips, tear trough, and cheeks. Bruising is possible at any injection site. Final results are visible at two weeks as swelling resolves and the product integrates into the tissue. Some treatments are best assessed and refined at a follow-up appointment four to six weeks later.
What it treats
HYALURONIC ACID FILLER — RESTYLANE
RADIESSE
IDEAL CANDIDATE
Dermal filler is appropriate for patients who want to address specific volume loss, structural change, or contour concerns in a precise, planned way. The right candidate has specific concerns to address — not someone seeking a general improvement, which is better served by skin quality treatments or a combination protocol designed at consultation.
At Veritas Backstage, the practice has been performing injectable filler since opening in 2010. Devon Perry — founder, cosmetic injector, and lead aesthetics practitioner — has been placing filler since 2004. The clinical philosophy is one of restraint: using the minimum volume needed to achieve the intended structural result, staging treatment across visits when appropriate, and always designing the plan around the patient’s facial anatomy rather than a standard template.
Results and maintenance
Hyaluronic acid fillers typically last twelve to eighteen months depending on area, product, and individual metabolism. Radiesse typically lasts twelve to eighteen months, with some patients maintaining results for up to two years. Both reduce gradually and naturally — patients rarely experience a sudden visible change.
Most patients schedule maintenance appointments every twelve months, with timing adjusted based on individual response. Filler can be combined with neurotoxin, biostimulators, or skin quality treatments as part of a broader aging pathway protocol.